alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment.
暂无分享,去创建一个
[1] Patrick T Caswell,et al. Endocytic recycling pathways: emerging regulators of cell migration. , 2006, Current opinion in cell biology.
[2] J. Qin,et al. VEGF-integrin interplay controls tumor growth and vascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] Wei Yan,et al. Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis. , 2008, Molecular biology of the cell.
[4] D. Cheresh,et al. The role of alphav integrins during angiogenesis. , 1998 .
[5] Daniel L. Gustafson,et al. Assessment of the biological and pharmacological effects of the ανβ3 and ανβ5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors , 2007 .
[6] F. Ross,et al. Superactivation of integrin alphavbeta3 by low antagonist concentrations. , 2001, Journal of cell science.
[7] T. Byzova,et al. Integrin signaling is critical for pathological angiogenesis , 2006, The Journal of experimental medicine.
[8] R. Kalluri,et al. Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties* , 2000, The Journal of Biological Chemistry.
[9] J. Hickman,et al. Blockade of αvβ3 and αvβ5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells , 2006 .
[10] T. Mikkelsen,et al. Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] O. Razorenova,et al. Integrin affinity modulation in angiogenesis , 2008, Cell cycle.
[12] Robert V Farese,et al. Normal Development, Wound Healing, and Adenovirus Susceptibility in β5-Deficient Mice , 2000, Molecular and Cellular Biology.
[13] D. Taverna,et al. A Direct Test of Potential Roles for β3 and β5 Integrins in Growth and Metastasis of Murine Mammary Carcinomas , 2005 .
[14] Chandra L. Theesfeld,et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[16] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[17] D. Hicklin,et al. Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice , 2004, Cancer Research.
[18] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[19] R. Soldi,et al. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2 , 1999, The EMBO journal.
[20] R. Hynes,et al. Novel Roles for α3β1 Integrin as a Regulator of Cytoskeletal Assembly and as a Trans-dominant Inhibitor of Integrin Receptor Function in Mouse Keratinocytes , 1998, The Journal of cell biology.
[21] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[22] D. Taverna,et al. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins , 2002, Nature Medicine.
[23] R. Kalluri. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. , 2002, Cold Spring Harbor symposia on quantitative biology.
[24] M. U. Naik,et al. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin αvβ3 specific , 2006, Journal of Cell Science.
[25] R. Hynes,et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. , 1999, The Journal of clinical investigation.
[26] H. Friess,et al. A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer , 2006, BMC Cancer.
[27] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[28] R. Stupp,et al. Integrin inhibitors reaching the clinic. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] C. Kahn,et al. Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis , 2002, Science.
[30] David A. Cheresh,et al. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins , 2001, The Journal of cell biology.
[31] J. Roes,et al. Ulcerative colitis and autoimmunity induced by loss of myeloid αv integrins , 2007, Proceedings of the National Academy of Sciences.
[32] A. Reynolds,et al. Integrins in angiogenesis: multitalented molecules in a balancing act , 2003, Cell and Tissue Research.
[33] J. Verweij,et al. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours , 2003 .
[34] D. Cheresh,et al. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.
[35] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[36] T. N. Campbell,et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] F. Sarkar,et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.
[38] D. Hicklin,et al. &bgr;3-Integrin Regulates Vascular Endothelial Growth Factor-A–Dependent Permeability , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[39] R. Hynes,et al. Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins , 1998, Cell.
[40] S. Baker,et al. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. , 2006, Cancer research.
[41] Kenneth P. Roos,et al. Autocrine VEGF Signaling Is Required for Vascular Homeostasis , 2007, Cell.
[42] M. Ginsberg,et al. Trans-dominant inhibition of integrin function. , 1996, Molecular biology of the cell.
[43] N. Killeen,et al. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function , 1999, Nature.
[44] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.
[45] T. Byzova,et al. Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis , 2007, Circulation research.